Research programme: sulfonyl hydrazine prodrugs - Vion

Drug Profile

Research programme: sulfonyl hydrazine prodrugs - Vion

Alternative Names: KS 119; KS 119W; R-KS 119W; S-KS 119W; VNP 40541

Latest Information Update: 08 Jan 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yale University
  • Developer Vion Pharmaceuticals
  • Class Hydrazines
  • Mechanism of Action Alkylating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Cancer

Most Recent Events

  • 17 Dec 2009 VPN 40541 is still available for licensing (
  • 17 Dec 2009 Suspended - Preclinical for Cancer in USA (unspecified route)
  • 25 Jun 2008 VPN 40541 is available for licensing (
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top